Soo Ik Chang

Title: The Innovative Contributions of Soo Ik Chang

Introduction

Soo Ik Chang is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of corneal endothelial wounds. His innovative approach has the potential to improve the quality of life for individuals suffering from eye-related ailments.

Latest Patents

Soo Ik Chang holds a patent for a pharmaceutical composition aimed at treating corneal endothelial wounds. This composition includes angiogenin as an effective ingredient. The invention focuses on a new topical therapeutic use of angiogenin, which is known to be involved in angiogenesis. It activates the PI3K/Akt/eNOS pathway in ocular corneal endothelium, enhancing the migration and proliferation of corneal endothelial cells that cannot self-proliferate. This advancement promotes the prevention and treatment of corneal endothelial cell wounds.

Career Highlights

Throughout his career, Soo Ik Chang has been associated with prominent institutions. He has worked with Chung Ang University Industry Academic Cooperation and Chungbuk National University Industry-Academic Cooperation Foundation. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to significant research initiatives.

Collaborations

Soo Ik Chang has collaborated with notable colleagues, including Kyu Wan Kim and Young Joo Shin. Their combined expertise has furthered research and development in the pharmaceutical sector, particularly in ocular health.

Conclusion

Soo Ik Chang's innovative work in the pharmaceutical field, particularly regarding corneal endothelial wounds, showcases his dedication to improving medical treatments. His contributions are paving the way for advancements in ocular health and patient care.